Alexion Pharma GmbH announced today that Camilla Harder Hartvig has joined the company as Senior Vice President and Head of Europe/Middle East/Africa/Canada (EMEAC). She will be leading the commercial activities of the regional function from Alexion’s EMEAC headquarters in Zurich, Switzerland.

Camilla has more than 20 years of experience in the pharmaceutical industry having worked in a broad spectrum of companies, including AstraZeneca, Novartis and Allergan, and across a variety of regions and countries. She has experience in a wide range of therapeutic areas, such as cardiovascular, diabetes, respiratory, CNS, ophthalmology, and oncology, in addition to in medical aesthetics, devices and generics. Camilla was most recently President, International Markets at Glenmark Pharmaceuticals, where she led the commercial organisation across the European, Russian, Asian and Latin American regions on a branded generics business in respiratory, oncology, and dermatology.